Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Filana Therapeutics (SAVA) Q4 2023 Earnings
SAVA
28
Feb
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.77
-0.68
-0.59
-0.5
Details
Expected EPS
-0.52
Actual EPS
-0.5
Surprise EPS
0.02
Surprise Percent
+3.85%
Description
Filana Therapeutics (SAVA) has reported earnings of -0.5 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login